Gynecologic Cancer

Top Story

Communication, education can break taboo of sexual dysfunction in patients with cancer

HemOnc Today, July 25, 2015

Increased attention to the importance of informed decision making fosters physician and patient communication throughout cancer treatment.

Yet, there is one conversation that still may not happen often enough: the one about sexual function.

There are myriad reasons why the subject is not broached. Physicians might think it is awkward to ask patients about such a personal topic. Patients, in turn, may be too embarrassed to ask their doctors about concerns related to sex post-treatment.

SupplementPublication Exclusive

Perspectives from ASCO 2015: A HemOnc Today Special Report

HemOnc Today, July 25, 2015
This year’s ASCO Annual Meeting featured the theme “Illumination and Innovation: Transforming Data into Learning.”As such, meeting organizers selected…

Should all women undergo BRCA1 or BRCA2 testing?

July 22, 2015
Only women with a family history of breast, ovarian, fallopian tube or peritoneal cancer should undergo testing for BRCA1 and BRCA2 mutations, according to the U.S…
FDA News

FDA grants orphan drug designation to DPX-Survivac for ovarian cancer

July 16, 2015
The FDA granted orphan drug designation to DPX-Survivac, an immunotherapeutic agent designed to treat all stages of ovarian cancer, according to a press release from the…
CME
Hematology Oncology Case Consults

The Patient with Chronic Lymphocytic Leukemia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with chronic lymphocytic leukemia.
More »
Meeting News Coverage Video
4131332248001 th

Antibody-drug conjugate shows promise for NSCLC, ovarian cancer

June 12, 2014
CHICAGO — Howard A. Burris, MD, chief medical officer at the Sarah Cannon Research Institute, offers his…
More »
CME
Hematology Oncology Case Consults

Diagnosis and Management of Hemophilia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of the patient with hemophilia supplemented with a case…
More »
Patricia Ganz, MD Cover StoryPublication Exclusive

Communication, education can break taboo of sexual dysfunction in patients with cancer

HemOnc Today, July 25, 2015
Increased attention to the importance of informed decision making fosters physician and patient communication throughout cancer treatment.Yet, there…
SupplementPublication Exclusive

Perspectives from ASCO 2015: A HemOnc Today Special Report

HemOnc Today, July 25, 2015
This year’s ASCO Annual Meeting featured the theme “Illumination and Innovation: Transforming Data into Learning.”As such, meeting…

Should all women undergo BRCA1 or BRCA2 testing?

July 22, 2015
Only women with a family history of breast, ovarian, fallopian tube or peritoneal cancer should undergo testing for BRCA1 and BRCA2 mutations…
FDA News

FDA grants orphan drug designation to DPX-Survivac for ovarian cancer

July 16, 2015
The FDA granted orphan drug designation to DPX-Survivac, an immunotherapeutic agent designed to treat all stages of ovarian cancer, according to a…
In the Journals

Ridaforolimus improves PFS, yet increases toxicity in advanced endometrial cancer

July 10, 2015
Oral ridaforolimus appeared active in patients with advanced endometrial cancer, according to the results of a phase 2 study.However, ridaforolimus…
In the Journals

Cervical lymph node metastases compromise survival of younger patients with thyroid cancer

July 10, 2015
The presence of cervical lymph node metastases appeared to worsen survival in younger patients with papillary thyroid cancer, according to study…
In the Journals

Menarche age, parity influence endometrial cancer risk for women with Lynch syndrome

July 8, 2015
Several hormonal factors — including later age at menarche, parity and hormonal contraceptive use — reduced the risk for endometrial…
Elisa V. Bandera, MD In the Journals

BMI should not influence chemotherapy dose reductions for ovarian cancer

July 7, 2015
Women with ovarian cancer who received paclitaxel and carboplatin dose reductions experienced poorer survival regardless of their body size…
Alexi Wright In the Journals

ASCO endorses ASTRO recommendations for postoperative radiation in endometrial cancer

July 6, 2015
ASCO has endorsed guidelines from the American Society of Radiation Oncology on radiation therapy after surgery for patients with endometrial cancer…
In the Journals

Incidence of high-grade cervical lesions has declined due to screening, vaccination

June 30, 2015
The incidence of high-grade cervical lesions has decreased in young women in the U.S. since the approval of HPV vaccines, according to study…
More Headlines »
morganatic-roan morganatic-roan